| Literature DB >> 31919405 |
Wenji Guo1, Georgina K Fensom2, Gillian K Reeves2, Timothy J Key2.
Abstract
BACKGROUND: Previous studies suggest a protective role of physical activity in breast cancer risk, largely based on self-reported activity. We aimed to clarify this association by examining breast cancer risk in relation to self-reported physical activity, informed by accelerometer-based measures in a large subset of participants.Entities:
Mesh:
Year: 2020 PMID: 31919405 PMCID: PMC7054300 DOI: 10.1038/s41416-019-0700-6
Source DB: PubMed Journal: Br J Cancer ISSN: 0007-0920 Impact factor: 7.640
Characteristics of the study population at recruitment, according to self-reported physical activity and menopausal status.
| Premenopausal | Postmenopausal | |||
|---|---|---|---|---|
| Quartile of physical activity | Bottom quartile (least active) | Top quartile (most active) | Bottom quartile (least active) | Top quartile (most active) |
| Age at recruitment (years), mean (SD) | 45.7 (3.6) | 45.7 (3.5) | 59.3 (5.5) | 60.4 (5.5) |
| Lowest socioeconomic quintile, % | 22.4 | 24.3 | 19.5 | 19.0 |
| Family history of breast cancer, % | 5.7 | 5.7 | 6.6 | 6.6 |
| Age at menarche (years), mean (SD) | 13.0 (1.6) | 13.1 (1.7) | 12.9 (1.6) | 13.0 (1.6) |
| Age at first birth (years), mean (SD) | 28.2 (5.6) | 27.3 (5.3) | 25.7 (5.0) | 25.2 (4.8) |
| Parity, mean (SD) | 1.5 (1.2) | 1.7 (1.2) | 1.8 (1.2) | 1.9 (1.2) |
| Ever oral contraceptive use, % | 89.6 | 89.4 | 81.1 | 78.0 |
| Age at menopause (years), mean (SD) | 49.7 (5.0) | 49.7 (5.2) | ||
| Current hormone replacement therapy use, % | 49.8 | 51.5 | ||
| Current smokers, % | 11.0 | 11.0 | 9.3 | 7.7 |
| One or more drinks weekly, % | 63.3 | 64.5 | 61.2 | 63.0 |
| Height (cm), mean (SD) | 164.1 (6.3) | 164.2 (6.2) | 162.1 (6.3) | 161.9 (6.1) |
| Body mass index (kg/m2), mean (SD) | 27.5 (5.9) | 25.6 (4.7) | 28.2 (5.6) | 26.3 (4.5) |
| Body fat mass (kg), mean (SD) | 27.9 (11.6) | 23.5 (9.4) | 29.5 (10.8) | 25.3 (8.8) |
| Plumper than average at age 10, % | 20.3 | 18.2 | 19.1 | 16.0 |
| Total physical activity (MET hrs/week), median (IQR) | 7.1 (3.8, 10.4) | 91.8 (71.3, 134.1) | 7.4 (4.0, 10.6) | 94.9 (72.4, 136.5) |
| Accelerometer physical activity (milli-gravity), mean (SD)* | 28.3 (7.4) | 34.4 (9.7) | 25.7 (6.7) | 30.3 (8.2) |
MET hrs/week metabolic equivalent hours per week; SD standard deviation
*Data were collected after recruitment between February 2013 and December 2015
Association between physical activity and risk of invasive breast cancer by menopausal status in UK Biobank (n = 174,160 women followed from 2006 to 2014).
| Self-reported physical activity quartiles | Median self-reported physical activity | Repeat median self-reported physical activity | Median accelerometer physical activity | Cases/total ( | Relative risk | Relative risk |
|---|---|---|---|---|---|---|
| (MET hrs/week) | (MET hrs/week) | (MET hrs/week) | (milli-gravity/week) | (95% g-s CI)a | (95% g-s CI)b | |
| 0–13.78 | 7.30 | 15.40 | 27.34 | 205/12,324 | 1.00 (0.87–1.15) | 1.00 (0.87–1.15) |
| 13.79–29.55 | 21.12 | 23.10 | 29.47 | 200/12,318 | 0.97 (0.84–1.11) | 0.95 (0.83–1.09) |
| 29.56–58.27 | 40.80 | 34.22 | 31.25 | 183/12,261 | 0.91 (0.79–1.05) | 0.89 (0.77–1.03) |
| ≥58.28 | 91.80 | 64.40 | 33.24 | 129/10,553 | 0.77 (0.65–0.92) | 0.75 (0.63–0.89) |
| Linear trend per 50 MET hours/week (corrected with repeat self-reported physical activity) | 0.77 (0.62–0.95) | 0.74 (0.60–0.92) | ||||
| P for trend | 0.015 | 0.008 | ||||
| Linear trend per 5 milli-gravity (using median accelerometer values) | 0.82 (0.69-0.97) | 0.79 (0.66-0.95) | ||||
| P for trend | 0.022 | 0.010 | ||||
| 0–13.78 | 7.53 | 13.20 | 25.12 | 614/31271 | 1.00 (0.92–1.08) | 1.00 (0.92–1.08) |
| 13.79–29.55 | 21.17 | 23.89 | 26.83 | 611/31,196 | 0.99 (0.91–1.07) | 1.01 (0.94–1.10) |
| 29.56–58.27 | 41.10 | 38.75 | 27.77 | 553/31255 | 0.88 (0.81–0.96) | 0.92 (0.84–1.00) |
| ≥58.28 | 95.10 | 63.10 | 29.39 | 537/32,982 | 0.83 (0.76–0.90) | 0.87 (0.80–0.95) |
| Linear trend per 50 MET hours/week (corrected with repeat self-reported physical activity) | 0.81 (0.73–0.91) | 0.85 (0.76–0.96) | ||||
| P for trend | 0.000 | 0.006 | ||||
| Linear trend per 5 milli-gravity (using median accelerometer values) | 0.79 (0.69–0.90) | 0.84 (0.73–0.96) | ||||
| P for trend | <0.001 | 0.010 | ||||
| P for heterogeneity by menopausal status (corrected with repeat self-reported physical activity) = 0.26 | ||||||
| P for heterogeneity by menopausal status (using median accelerometer values) = 0.61 | ||||||
MET hrs/week metabolic equivalent hours per week; g-s CI group-specific confidence interval
aStratified by age at recruitment, region of recruitment and socioeconomic status. Adjusted for family history of breast cancer, height, parity, age at menarche, oral contraceptive use, age at first birth, smoking status, ever had breast cancer screening, alcohol intake frequency, age at menopause and HRT use (only in postmenopausal women)
bFurther adjusted for quartiles of body fat mass within each menopausal status group
Fig. 1Association between physical activity and risk of invasive breast cancer.
Self-reported physical activity was grouped into quartiles. Relative risk for the association between self-reported physical activity and risk of invasive breast cancer is plotted against the median repeat assessment physical activity value within each quartile of baseline self-reported physical activity. The analysis is stratified by age at recruitment, region of recruitment and socioeconomic status, and is adjusted for family history of breast cancer, height, number of births, age at menarche, age at first birth, oral contraceptive use, ever had breast cancer screening, smoking status, alcohol intake frequency, hormone replacement therapy use, age at menopause and a variable generated by the cross-classification of body fat mass and menopausal status. The figure shows point estimates and 95% group-specific confidence intervals. CI, confidence interval.
Fig. 2Relative risk of physical activity and breast cancer risk by BMI, ever use of HRT, number of births and alcohol intake.
Analyses are stratified by age at recruitment, region of recruitment and socioeconomic status, and are adjusted for family history of breast cancer, height, number of births, age at menarche, age at first birth, oral contraceptive use, ever had breast cancer screening, smoking status, alcohol intake frequency, hormone replacement therapy use, age at menopause and a variable generated by the cross-classification of body fat mass and menopausal status. Analyses of BMI <25 kg/m2 and 25 kg/m2 or more were adjusted for a BMI group-specific variable generated by the cross-classification of body fat mass and menopausal status instead of the overall cross-classified variable. Analyses stratified by ever use of hormone replacement therapy were restricted to postmenopausal women. The figure shows the linear trend per 50 MET hours/week of self-reported physical activity for each subgroup and 95% group-specific confidence intervals. BMI, body mass index; HRT, hormone replacement therapy; RR, relative risk. Note: The number of cases does not sum to the total, as information on ever use of HRT was missing for 4 postmenopausal cases and information on the number of births was missing for 2 cases.